Prevalence and genetic analysis of multidrug-resistant Pseudomonas aeruginosa ST235 isolated from a hospital in Korea, 2008-2012

Annals of Clinical and Laboratory Science

Volumn 43, Issue 4, 2013, Pages 414-419

  Cho, Hye Hyun ^a,b   Kwon, Kye Chul ^a   Sung, Ji Youn ^c   Koo, Sun Hoe ^a  

^a Chungnam National University   (South Korea)

^b Jeonju Kijeon College   (South Korea)

^c Far East University   (South Korea)

Author keywords

AME genes; IMP 6 producing P. aeruginosa; ST235

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL PROTEIN; CARBAPENEM; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PROTEIN IMP 6; PROTEIN VIM 2; TOBRAMYCIN; UNCLASSIFIED DRUG; ACYLTRANSFERASE; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BETA LACTAMASE;

AGAR DILUTION; AME GENE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLONE; DNA SEQUENCE; GENETIC ANALYSIS; HOSPITAL INFECTION; INTEGRON; KOREA; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OPPORTUNISTIC INFECTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; CROSS INFECTION; GENETICS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SOUTH KOREA;

ACETYLTRANSFERASES; AMINOGLYCOSIDES; ANTI-INFECTIVE AGENTS; BASE SEQUENCE; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; PREVALENCE; PSEUDOMONAS AERUGINOSA; REPUBLIC OF KOREA; SEQUENCE ANALYSIS, DNA;

EID: 84889007841     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Yoo JS, Yang JW, Kim HM, Byeon J, Kim HS, Yoo JI, Chung GT, Lee YS. Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea. Int J Antimicrob Agents 2012;39:300-304.
2. Hammami S, Boutiba-Ben Boubaker I, Ghozzi R, Saidani M, Amine S, Ben Redjeb S. Nosocomial outbreak of imipenemresistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit. Diagn Pathol 2011;6:106.
3. Lee JY, Ko KS. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int J Antimicrob Agents 2012;40:168-172.
4. Lee K, Kim MN, Kim JS, Hong HL, Kang JO, Shin JH, Park YJ, Yong D, Jeong SH, Chong Y;KONSAR Group. Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009. Yonsei Med J 2011;52:793-802.
5. Lee H, Kim CK, Lee J, Lee SH, Ahn JY, Hong SG, Park YJ, Jeong SH, Kim EC, Lee WK, Uh Y, Shin J Hee, Choi TY, Kwak HS, Lee K. Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea in 2005 and 2006. Korean J Clin Microbiol 2007;10:59-69.
6. Van der Bij AK, Van der Zwan D, Peirano G, Severin JA, Pitout JD, Van Westreenen M, Goessens WH;MBL-PA Surveillance Study Group. Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type. Clin Microbiol Infect 2012;18:E369-72.
7. Khosravi Y, Loke MF, Chua EG, Tay ST, Vadivelu J. Phenotypic detection of metallo-β-lactamase in imipenem-resistant Pseudomonas aeruginosa. ScientificWorldJournal 2012;2012:654939.
8. Seok Y, Bae IK, Jeong SH, Kim SH, Lee H, Lee K. Dissemination of IMP-6 metallo-β-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea. J Antimicrob Chemother 2011;66:2791-2796.
9. Samuelsen O, Toleman MA, Sundsfjord A, Rydberg J, Leegaard TM, Walder M, Lia A, Ranheim TE, Rajendra Y, Hermansen NO, Walsh TR, Giske CG. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother 2010;54:346-352.
10. Cholley P, Thouverez M, Hocquet D, van der Mee-Marquet N, Talon D, Bertrand X. Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types. J Clin Microbiol 2011;49:2578-2583.
11. Kim JY, Park YJ, Kwon HJ, Han K, Kang MW, Woo GJ. Occurrence and mechanisms of amikacin resistance and its association with beta-lactamases in Pseudomonas aeruginosa: a Korean nationwide study. J Antimicrob Chemother 2008;62:479-483.
12. Vaziri F, Peerayeh SN, Nejad QB, Farhadian A. The prevalence of aminoglycoside-modifying enzyme genes (aac (6')-I, aac (6')-II, ant (2")-I, aph (3')-VI) in Pseudomonas aeruginosa. Clinics (Sao Paulo) 2011;66:1519-1522.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement, M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA, 2010.
14. Kirikae T, Mizuguchi Y, Arakawa Y. Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan. J Antimicrob Chemother 2008;61:612-615.
15. Sung JY, Koo SH, Kwon KC, Park JW, Ko CS, Shin SY, Song JH. Characterization of Class 1 Integrons in Metallo-β-lactamase-producing Pseudomonas aeruginosa. Korean J Clin Microbiol 2009;12:17-23.
16. Hu LF, Chang X, Ye Y, Wang ZX, Shao YB, Shi W, Li X, Li JB. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int J Antimicrob Agents 2011;37:230-234.
17. Akers KS, Chaney C, Barsoumian A, Beckius M, Zera W, Yu X, Guymon C, Keen EF 3rd, Robinson BJ, Mende K, Murray CK. Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex. J Clin Microbiol 2010;48:1132-1138.
18. Bogaerts P, Galimand M, Bauraing C, Deplano A, Vanhoof R, De Mendonca R, Rodriguez-Villalobos H, Struelens M, Glupczynski Y. Emergence of armA and rmtB aminoglycoside resistance 16S rRNA methylases in Belgium. J Antimicrob Chemother 2007;59:459-464.
19. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallobeta-lactamases: the quiet before the storm? Clin Microbiol Rev 2005;18:306-325.
20. Queenan AM, Bush K. Carbapenemases: the versatile betalactamases. Clin Microbiol Rev 2007;20:440-458.
21. Yano H, Kuga A, Okamoto R, Kitasato H, Kobayashi T, Inoue M. Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 2001;45:1343-1348.
22. Jeong JH, Shin KS, Lee JW, Park EJ, Son SY. Analysis of a novel class 1 integron containing metallo-beta-lactamase gene VIM-2 in Pseudomonas aeruginosa. J Microbiol 2009;47:753-759.
23. Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005;49:479-487.
24. Miller GH, Sabatelli FJ, Hare RS, Glupczynski Y, Mackey P, Shlaes D, Shimizu K, Shaw KJ. The most frequent aminoglycoside resistance mechanismschanges with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin Infect Dis 1997;24(Suppl 1):S46-62.
25. Busch-Sørensen C, Sönmezoglu M, Frimodt-Møller N, Højbjerg T, Miller GH, Espersen F. Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp. from two Danish hospitals: correlation with type of aminoglycoside used. APMIS 1996;104:763-768.
26. Over U, Gür D, Unal S, Miller GH;Aminoglycoside Resistance Study Group. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin Microbiol Infect 2001;7:470-478.
27. Yokoyama K, Doi Y, Yamane K, Kurokawa H, Shibata N, Shibayama K, Yagi T, Kato H, Arakawa Y. Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 2003;362:1888-1893.
28. Doi Y, Ghilardi AC, Adams J, de Oliveira Garcia D, Paterson DL. High prevalence of metallo-beta-lactamase and 16S rRNA methylase coproduction among imipenem-resistant Pseudomonas aeruginosa isolates in Brazil. Antimicrob Agents Chemother 2007;51:3388-3390.